Frampton, James E <br/><br/>
Vandetanib: in medullary thyroid cancer.  [electronic resource] 

 -  Drugs  Jul 2012 
 - 1423-36 p.  digital 
<br/><br/> Publication Type: Journal Article; Review 
<br/><br/><label>ISSN: </label>1179-1950 
<br/><br/><label>Standard No.: </label>10.2165/11209300-000000000-00000  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Administration, Oral<br/>Antineoplastic Agents--administration & dosage<br/>Carcinoma, Neuroendocrine<br/>Disease-Free Survival<br/>Humans<br/>Molecular Structure<br/>Neoplasm Metastasis<br/>Piperidines--administration & dosage<br/>Protein-Tyrosine Kinases--antagonists & inhibitors<br/>Quinazolines--administration & dosage<br/>Randomized Controlled Trials as Topic<br/>Thyroid Neoplasms--drug therapy